Before I proceed to enrage half of Silicon Valley with data, a quick introduction for the uninitiated:
Rebel Fund invests in the top 10% of Y Combinator startups, with a portfolio of now 300+ companies valued collectively in the tens of billions. Along the way, we’ve invested millions into building the most comprehensive dataset of YC startups, founders, and outcomes that exists outside of YC itself, with millions of datapoints across every YC batch in history. We use this data primarily to train our proprietary Rebel Theorem 5.0 ML/AI model to predict YC startup success, but it’s also helped me publish dozens of data-driven posts answering interesting questions about YC startup investing. Today we’ll dive into whether the most expensive YC startups in each batch are worth the premium.
To answer this, we looked at 642 companies from the 2021–2024 batches where we have Demo Day SAFE valuation cap data. Here are our findings:
Higher-priced companies do better. Companies priced above their batch median reached Series A or beyond 25% of the time, against 8% for those below it — that’s a three times higher Series A+ graduation rate for the more expensive companies.
They also failed less. 16% of below-median valuation companies have shut down vs 6% above the median — that’s a three times lower failure rate.
Vintage does not explain it. Compare each company only against others from its own batch and the findings are consistent across vintages.
Rebel’s involvement does not explain it. This holds across the companies we didn’t invest in (those we invest in perform better across valuations)
Higher cap does not mean a bigger winner. This is the big caveat — we know that expensive companies enjoy higher Series A+ graduation rates and lower failure rates, but it’s unclear whether they’ll enjoy bigger exits.
Let me start by addressing the elephant in the room: YC startups are expensive and they’re only getting more so.

From the W21 to P26 batches, median YC SAFE caps of the companies Rebel interviewed nearly tripled from $15M to $40M. There is certainly a ‘YC premium’ (though our outcomes data shows it’s worth paying).
Even within these already-expensive YC batches, there are a number of companies raising at valuation caps well above their batch average, giving pause to many seed investors. However, near-term outcomes are dramatically better for the more expensive companies…

…and this holds true at every price level…

…and if you plot the relationship between SAFE caps at Demo Day vs whether companies go on to raise Series A+ rounds, you get a nearly perfect line, meaning the former is a very consistent predictor of the latter¹.

Interestingly, Rebel portcos with lower Demo Day valuations perform nearly as well as those with higher valuations, and our companies perform much better than their YC peers across every valuation range.

I think this is partially thanks to our portfolio support, but mostly a combination of our partners’ picking ability and our Rebel Theorem ML/AI algorithm, which looks at hundreds of characteristics of every YC startup and founder. The algorithm often picks up signals that are highly predictive of future outcomes yet unknown to other investors, and thus don’t drive up company valuations.
Still, Rebel tends to invest in the more expensive half of each YC batch, even though we don’t treat price as a signal one way or the other.

We also found the startups Rebel invests in enjoy a much higher success (Series A+ graduation) to failure (shut down) ratio than their YC peers. Our portfolio success-to-failure ratio is ~6:1 vs ~1:1 for the companies we passed on.

And the stronger our interviewing partner’s recommendation was for a company, the better their outcome:

If you were to only invest in YC companies that 1) have a higher SAFE cap, and 2) Rebel invested in, you’d perform about 6x better than YC averages in terms of Series A graduation rate. That would be a superb investment strategy, except very few of you could get into these rounds :-)
Before every investor who reads this starts aping into high-valuation YC startups and every YC founder starts hiking up their SAFE cap to improve their chances of raising a Series A, let me share some caveats:
Correlation does not imply causation. Near-term success is strongly correlated with higher valuation caps at Demo Day, but not caused by them. Companies that raise at higher valuations typically have stronger teams, bigger markets, and more traction to date. At Rebel, we often pass on high-valuation companies, even knowing these statistics, if we don’t feel their valuation is justified.
Series A graduation rate isn’t destiny. While raising a Series A+ is definitely a good sign, what ultimately matters to founders and investors is exit valuation and dilution. This analysis shows that high-valuation companies are safer, but not necessarily better in terms of long-term outcomes.
Buy low, sell high. The old investing adage still applies. The best skill a seed investor can have is identifying ‘hidden gem’ startups with lower entry valuations that end up having exceptional exits. That’s what we aim to do at Rebel — we’re just not afraid to invest in a strong company that also happens to have a higher valuation, so long as it fits within our target range.
Investors and founders, do as you wish with this analysis, please just don’t shoot the messenger 😂
¹The best-fit line has a log-odds coefficient of ~1.66, so doubling a company’s SAFE cap relative to its batch multiplies its Series A+ odds by ~3.1x. In other words, the more expensive companies are still “good buys” even after accounting for their higher prices.

